Webcast Recording: Tissue-Based CDx Development and Image Analysis in a Regulated Space

Recently Flagship hosted a webcast on Tissue-Based CDx Development and Image Analysis in a Regulated space. Our discussion stems from the fact that the United States Food and Drug Administration (FDA) requires comprehensive analytical validation and clinical evaluation of new in vitro diagnostic (IVD) tests as companion diagnostics (CDx) to demonstrate that an IVD is safe and effective. We covered that a CDx can be an IVD or imaging tool.

As precision-based medicine expands across therapeutic areas like oncology, accompanying diagnostics are greatly optimized by digital image analysis (IA) tools that support pathologist decisions. To maximize budget, time, and other resources, it is important that CDx development is understood early in the context of existing regulations and the specifics of a drug development program.

Moderated by Meredith James, Chief Operating Officer, Flagship Biosciences, our multidisciplinary panel of experts provided insights into tissue-based (biomarker) IVDs/CDx development and how the integration of IA tools can advance and accelerate CDx development from drug discovery to clinical trials and drug approval.

Our expert panelists included:

  • David Sidransky, M.D., Professor of Oncology, Otolaryngology, Urology, Pathology, and Genetics, The Johns Hopkins University
  • Mike Kagey, Ph.D., Senior Director of Translational Medicine, Leap Therapeutics 
  • Suzana Corritori, M.D., M.S., President, Corritori Consulting
  • Roberto Gianani, M.D., Chief Medical Officer, Flagship Biosciences

You’ll even get to hear a bit of a case study from Mike at Leap Therapeutics. 

Or if you’re ready to schedule a consultation with Flagship to discuss your drug development or regulatory challenges, contact us!

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

AACR Annual Meeting 2024

Meet with us at the AACR Annual Meeting 2024 to learn about our spatial biology solutions. Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the...

Spatial Biology for Immuno-Oncology Summit 2024

Meet with us at the Spatial Biology for Immuno-Oncology Summit.The Spatial Biology for Immuno-Oncology Summit is back for its second year, and Flagship Biosciences is a Program Partner for the event. Join us January 23-25 in San Diego where key industry leaders will...

65th ASH Annual Meeting and Exposition

Meet with us at the American Society of Hematology annual meeting in December. Whether you’re engaged in basic research or drug development, our genomics solutions offer valuable insights to help you achieve your goals. We offer the highest quality results and support...

Society for Immunotherapy of Cancer Annual Meeting

Visit Flagship at SITC 2023 Booth #716. November 3-5, 2023. We offer a comprehensive set of discovery, translational and clinical testing, and assay development services to support your clinical studies in immune-oncology and immunotherapy. From the selection of...

Spatial Biology for Drug Development Summit

Visit Flagship at the Spatial Biology for Drug Development Summit. October 11-13, 2023. Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is...